查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1580033

连网型给药市场：按产品、技术、治疗领域、分销管道和最终用户 - 2025-2030 年全球预测

Connected Drug Delivery Devices Market by Product (Connected Injection Devices, Smart Inhalers, Smart Pills), Technology (Bluetooth, Near Field Communication, Wi-Fi), Therapy Area, Distribution Channel, End User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 190 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年连网型药物输送市场价值为8.5317亿美元，预计到2024年将达到9.6622亿美元，复合年增长率为14.45%，到2030年将达到21.9537亿美元。

连网型药物输送是指先进的医疗设备，可实现药物管理，同时实现患者用药依从性和治疗结果的即时监控和资料收集。由于对个人化医疗保健、以患者为中心的治疗模式以及物联网在医疗技术中的整合的需求不断增加，这一范围变得越来越重要。这些设备在慢性病管理领域有着重要的应用，包括使用连网型胰岛素笔进行糖尿病管理、使用智慧吸入器进行气喘治疗以及使用穿戴式註射器进行肿瘤治疗。主要最终用途包括医院、家庭护理场所和门诊病人设施，大大提高了患者的依从性并实现远端监控。

主要市场统计
基准年[2023] 8.5317 亿美元
预测年份 [2024] 96622万美元
预测年份 [2030] 21.9537亿美元
复合年增长率（%） 14.45%

市场正受到慢性病增加、数位健康技术进步以及人们日益关注降低医疗保健成本等因素的影响。最新的机会在于开发人工智慧主导的分析，以提高患者洞察力、增强设备互通性并扩展针对新出现的健康问题的应用。鼓励公司投资与科技公司和医疗保健提供者的伙伴关係，以利用资料分析并提高设备的可访问性。

然而，高开发成本、资料隐私问题和监管障碍等挑战可能会阻碍成长。一些患者群体和医疗保健专业人员不愿采用该技术，以及对设备可靠性和寿命的担忧，也阻碍了市场渗透。创新应着重于提高这些设备的准确性和整合能力，开发自适应演算法以确保更准确的剂量和患者回馈循环。

此外，保护病患资料的网路安全措施也很重要。小型化和延长电池寿命方面的创新可以帮助其从竞争对手中脱颖而出。该市场的特点是技术发展速度快，需要相关人员不断适应和适应。了解患者需求、监管环境和技术进步对于在这个充满活力的市场中保持永续成长轨迹至关重要。

市场动态：揭示快速发展的连网型药物输送市场的关键市场洞察

供需的动态交互作用正在改变连网型的药物输送市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，并了解消费行为及其对製造成本的影响，并更清楚地了解对采购趋势的影响。

  • 市场驱动因素
    • 世界各地慢性病和残疾的增加
    • 连网型药物传输的支持性监管核准
    • 政府支持政策，改善不同背景患者获得医疗保健解决方案的机会
  • 市场限制因素
    • 连网型药物传递的准确性和有效性的复杂性
  • 市场机会
    • 持续创新，提高连网型给药的安全性和功能性
    • 采用连网型给药进行个人化医疗的可能性
  • 市场挑战
    • 与使用连网型药物传输相关的隐私和资料安全问题

波特五力：驾驭连网型药物传输市场的策略工具

波特的五力框架是了解连网型药物输送市场竞争格局的关键工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解连网型药物输送市场的外部影响

外部宏观环境因素在塑造连网型药物传输市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析 了解连网型药物输送市场的竞争格局

对连网型药物输送市场的详细市场占有率分析可以对供应商绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵连网型药物传输市场供应商的绩效评估

FPNV 定位矩阵是评估连网型药物传输市场供应商的关键工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议描绘了连网型药物输送市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，连网型药物输送市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：详细检视当前市场环境、主要企业的广泛资料、评估其在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5.产品开发与创新：重点关注可望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 世界各地慢性病和残疾的发生率正在上升
      • 支持连网型药物输送的监管核准
      • 政府支持政策，改善不同背景病患获得医疗保健解决方案的机会
    • 抑制因素
      • 连网型药物传递准确性和有效性的复杂性
    • 机会
      • 持续创新，提高连网型给药的安全性和功能性
      • 在个人化医疗中引入连网型药物传递的可能性
    • 任务
      • 与使用连网型药物传输相关的隐私问题和资料安全问题
  • 市场区隔分析
    • 产品：智慧吸入器的新进展与创新
    • 治疗领域：需要连网型给药以促进呼吸系统疾病的即时监测
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章连网型药物传输市场：副产品

  • 连接注射装置
  • 智慧吸入器
  • 智慧药丸

第七章连网型药物输送市场：依技术分类

  • Bluetooth
  • 近距离场通讯
  • Wi-Fi

第八章依治疗领域连网型药物传输市场

  • 心血管疾病
  • 糖尿病
  • 神经病学
  • 呼吸系统疾病

第 9 章连网型药物输送市场：按分销管道

  • 医院及临床药房
  • 网路平台
  • 药局

第 10 章连网型药物输送市场：依最终使用者分类

  • 家庭护理设置
  • 医院/诊所
  • 研发中心

第十一章美洲连网型给药市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十二章亚太连网型药物传输市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十三章欧洲、中东和非洲的连网型给药市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第14章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • Aptar Digital Health 与 SHL Medical 合作，透过自行注射给药装置改善患者体验
    • Aherium 的智慧吸入器已被核准用于Astra Zeneca的设备，增强连网型药物输送
    • 新伙伴关係推出智慧型设备，用于气喘和慢性阻塞性肺病的个人化护理
  • 战略分析和建议

公司名单

  • Abbott Laboratories
  • Adherium Limited
  • AptarGroup, Inc.
  • Becton, Dickinson, and Company
  • Cognita Labs LLC
  • Eli Lilly and Company
  • F. Hoffmann-La Roche AG
  • Findair Sp. z oo
  • Gerresheimer AG
  • Medtronic PLC
  • Merck KGaA
  • Molex LLC
  • Novartis AG
  • Novo Nordisk A/S
  • OPKO Health, Inc.
  • Otsuka America, Inc.
  • Presspart Verwaltungs-GmbH
  • ResMed Inc.
  • SHL Medical AG
  • Sulzer Ltd.
  • Teva Pharmaceutical Industries Ltd.
  • Viatris Inc.
  • West Pharmaceutical Services, Inc.
  • Ypsomed Holding
  • Zimmer Biomet Holdings, Inc.
Product Code: MRR-3C68ED2D0A4A

The Connected Drug Delivery Devices Market was valued at USD 853.17 million in 2023, expected to reach USD 966.22 million in 2024, and is projected to grow at a CAGR of 14.45%, to USD 2,195.37 million by 2030.

Connected Drug Delivery Devices refer to advanced medical devices that allow for the administration of medication while simultaneously enabling real-time monitoring and data collection concerning a patient's adherence and therapeutic outcomes. This scope is increasingly essential due to rising demands for personalized healthcare, patient-centric treatment models, and the integration of IoT in medical technologies. These devices find substantial application across chronic disease management, including diabetes management through connected insulin pens, asthma care via smart inhalers, and oncology treatments using wearable injectors. Hospitals, home care settings, and outpatient facilities constitute the primary end-use landscapes, significantly enhancing patient compliance and enabling remote monitoring.

KEY MARKET STATISTICS
Base Year [2023] USD 853.17 million
Estimated Year [2024] USD 966.22 million
Forecast Year [2030] USD 2,195.37 million
CAGR (%) 14.45%

The market is influenced by factors such as the increasing prevalence of chronic diseases, technological advancements in digital health, and a growing emphasis on reducing healthcare costs. Latest opportunities lie in developing AI-driven analytics for improved patient insights, enhancing device interoperability, and expanding applications across emerging health concerns. Companies are recommended to invest in partnerships with tech firms and healthcare providers to leverage data analytics and improve device accessibility.

However, challenges such as high development costs, data privacy issues, and regulatory hurdles may impede growth. Market penetration also suffers from resistance to technological adoption among some patient populations and healthcare professionals, alongside concerns about device reliability and lifetime. Innovation should focus on improving the accuracy and integration capabilities of these devices and developing adaptive algorithms that ensure more precise dosing and patient feedback loops.

Furthermore, emphasizing cybersecurity measures to safeguard patient data will be crucial. Innovations in miniaturization and battery life extension may drive competitive differentiation. The market is characterized by a fast-paced technological evolution, requiring continuous adaptation and resilience from stakeholders. Understanding patient needs, regulatory landscapes, and technological advancements are vital to maintaining a sustainable growth trajectory in this dynamic market.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Connected Drug Delivery Devices Market

The Connected Drug Delivery Devices Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising incidences of chronic diseases and disorders across the world
    • Supportive regulatory approvals for connected drug delivery devices
    • Supportive government policies to improve access to healthcare solutions for patients from diverse backgrounds
  • Market Restraints
    • Complexities in the accuracy and efficacy of connected drug delivery devices
  • Market Opportunities
    • Ongoing innovations to improve the safety and functionality of connected drug delivery devices
    • Potential for the adoption of connected drug delivery devices for personalized medicine
  • Market Challenges
    • Privacy concerns and data security issues associated with the usage of connected drug delivery devices

Porter's Five Forces: A Strategic Tool for Navigating the Connected Drug Delivery Devices Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Connected Drug Delivery Devices Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Connected Drug Delivery Devices Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Connected Drug Delivery Devices Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Connected Drug Delivery Devices Market

A detailed market share analysis in the Connected Drug Delivery Devices Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Connected Drug Delivery Devices Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Connected Drug Delivery Devices Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Connected Drug Delivery Devices Market

A strategic analysis of the Connected Drug Delivery Devices Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Connected Drug Delivery Devices Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Adherium Limited, AptarGroup, Inc., Becton, Dickinson, and Company, Cognita Labs LLC, Eli Lilly and Company, F. Hoffmann-La Roche AG, Findair Sp. z o. o., Gerresheimer AG, Medtronic PLC, Merck KGaA, Molex LLC, Novartis AG, Novo Nordisk A/S, OPKO Health, Inc., Otsuka America, Inc., Presspart Verwaltungs-GmbH, ResMed Inc., SHL Medical AG, Sulzer Ltd., Teva Pharmaceutical Industries Ltd., Viatris Inc., West Pharmaceutical Services, Inc., Ypsomed Holding, and Zimmer Biomet Holdings, Inc..

Market Segmentation & Coverage

This research report categorizes the Connected Drug Delivery Devices Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Connected Injection Devices, Smart Inhalers, and Smart Pills.
  • Based on Technology, market is studied across Bluetooth, Near Field Communication, and Wi-Fi.
  • Based on Therapy Area, market is studied across Cardiovascular Diseases, Diabetes, Neurology, and Respiratory Diseases.
  • Based on Distribution Channel, market is studied across Hospitals & Clinical Pharmacies, Online Platforms, and Pharmacies.
  • Based on End User, market is studied across Homecare Settings, Hospitals & Clinics, and Research & Development Centers.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising incidences of chronic diseases and disorders across the world
      • 5.1.1.2. Supportive regulatory approvals for connected drug delivery devices
      • 5.1.1.3. Supportive government policies to improve access to healthcare solutions for patients from diverse backgrounds
    • 5.1.2. Restraints
      • 5.1.2.1. Complexities in the accuracy and efficacy of connected drug delivery devices
    • 5.1.3. Opportunities
      • 5.1.3.1. Ongoing innovations to improve the safety and functionality of connected drug delivery devices
      • 5.1.3.2. Potential for the adoption of connected drug delivery devices for personalized medicine
    • 5.1.4. Challenges
      • 5.1.4.1. Privacy concerns and data security issues associated with the usage of connected drug delivery devices
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product: Emerging advancements and innovations in smart inhalers
    • 5.2.2. Therapy Area: Need for connected drug delivery devices to facilitate real-time monitoring of respiratory diseases
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Connected Drug Delivery Devices Market, by Product

  • 6.1. Introduction
  • 6.2. Connected Injection Devices
  • 6.3. Smart Inhalers
  • 6.4. Smart Pills

7. Connected Drug Delivery Devices Market, by Technology

  • 7.1. Introduction
  • 7.2. Bluetooth
  • 7.3. Near Field Communication
  • 7.4. Wi-Fi

8. Connected Drug Delivery Devices Market, by Therapy Area

  • 8.1. Introduction
  • 8.2. Cardiovascular Diseases
  • 8.3. Diabetes
  • 8.4. Neurology
  • 8.5. Respiratory Diseases

9. Connected Drug Delivery Devices Market, by Distribution Channel

  • 9.1. Introduction
  • 9.2. Hospitals & Clinical Pharmacies
  • 9.3. Online Platforms
  • 9.4. Pharmacies

10. Connected Drug Delivery Devices Market, by End User

  • 10.1. Introduction
  • 10.2. Homecare Settings
  • 10.3. Hospitals & Clinics
  • 10.4. Research & Development Centers

11. Americas Connected Drug Delivery Devices Market

  • 11.1. Introduction
  • 11.2. Argentina
  • 11.3. Brazil
  • 11.4. Canada
  • 11.5. Mexico
  • 11.6. United States

12. Asia-Pacific Connected Drug Delivery Devices Market

  • 12.1. Introduction
  • 12.2. Australia
  • 12.3. China
  • 12.4. India
  • 12.5. Indonesia
  • 12.6. Japan
  • 12.7. Malaysia
  • 12.8. Philippines
  • 12.9. Singapore
  • 12.10. South Korea
  • 12.11. Taiwan
  • 12.12. Thailand
  • 12.13. Vietnam

13. Europe, Middle East & Africa Connected Drug Delivery Devices Market

  • 13.1. Introduction
  • 13.2. Denmark
  • 13.3. Egypt
  • 13.4. Finland
  • 13.5. France
  • 13.6. Germany
  • 13.7. Israel
  • 13.8. Italy
  • 13.9. Netherlands
  • 13.10. Nigeria
  • 13.11. Norway
  • 13.12. Poland
  • 13.13. Qatar
  • 13.14. Russia
  • 13.15. Saudi Arabia
  • 13.16. South Africa
  • 13.17. Spain
  • 13.18. Sweden
  • 13.19. Switzerland
  • 13.20. Turkey
  • 13.21. United Arab Emirates
  • 13.22. United Kingdom

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2023
  • 14.2. FPNV Positioning Matrix, 2023
  • 14.3. Competitive Scenario Analysis
    • 14.3.1. Aptar Digital Health and SHL Medical Collaborate to Enhance Patient Experience with Self-Injectable Drug Delivery Devices
    • 14.3.2. Adherium's Smartinhaler Approved for Use with AstraZeneca Devices, Enhancing Connected Drug Delivery
    • 14.3.3. New Partnership Launches Smart Devices for Tailored Asthma and COPD Care
  • 14.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. Adherium Limited
  • 3. AptarGroup, Inc.
  • 4. Becton, Dickinson, and Company
  • 5. Cognita Labs LLC
  • 6. Eli Lilly and Company
  • 7. F. Hoffmann-La Roche AG
  • 8. Findair Sp. z o. o.
  • 9. Gerresheimer AG
  • 10. Medtronic PLC
  • 11. Merck KGaA
  • 12. Molex LLC
  • 13. Novartis AG
  • 14. Novo Nordisk A/S
  • 15. OPKO Health, Inc.
  • 16. Otsuka America, Inc.
  • 17. Presspart Verwaltungs-GmbH
  • 18. ResMed Inc.
  • 19. SHL Medical AG
  • 20. Sulzer Ltd.
  • 21. Teva Pharmaceutical Industries Ltd.
  • 22. Viatris Inc.
  • 23. West Pharmaceutical Services, Inc.
  • 24. Ypsomed Holding
  • 25. Zimmer Biomet Holdings, Inc.

LIST OF FIGURES

  • FIGURE 1. CONNECTED DRUG DELIVERY DEVICES MARKET RESEARCH PROCESS
  • FIGURE 2. CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPY AREA, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPY AREA, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 15. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. AMERICAS CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. AMERICAS CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. UNITED STATES CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 19. UNITED STATES CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. ASIA-PACIFIC CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 23. EUROPE, MIDDLE EAST & AFRICA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 24. CONNECTED DRUG DELIVERY DEVICES MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 25. CONNECTED DRUG DELIVERY DEVICES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. CONNECTED DRUG DELIVERY DEVICES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. CONNECTED DRUG DELIVERY DEVICES MARKET DYNAMICS
  • TABLE 7. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY CONNECTED INJECTION DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY SMART INHALERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY SMART PILLS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY BLUETOOTH, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY NEAR FIELD COMMUNICATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY WI-FI, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DIABETES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY RESPIRATORY DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY HOSPITALS & CLINICAL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY ONLINE PLATFORMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY HOMECARE SETTINGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY RESEARCH & DEVELOPMENT CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 33. AMERICAS CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 34. ARGENTINA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 35. ARGENTINA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 36. ARGENTINA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
  • TABLE 37. ARGENTINA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 38. ARGENTINA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 39. BRAZIL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 40. BRAZIL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 41. BRAZIL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
  • TABLE 42. BRAZIL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 43. BRAZIL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 44. CANADA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 45. CANADA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 46. CANADA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
  • TABLE 47. CANADA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 48. CANADA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 49. MEXICO CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 50. MEXICO CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 51. MEXICO CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
  • TABLE 52. MEXICO CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 53. MEXICO CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 54. UNITED STATES CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 55. UNITED STATES CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 56. UNITED STATES CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
  • TABLE 57. UNITED STATES CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 58. UNITED STATES CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 59. UNITED STATES CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 60. ASIA-PACIFIC CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 61. ASIA-PACIFIC CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 62. ASIA-PACIFIC CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
  • TABLE 63. ASIA-PACIFIC CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 64. ASIA-PACIFIC CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 65. ASIA-PACIFIC CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 66. AUSTRALIA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 67. AUSTRALIA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 68. AUSTRALIA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
  • TABLE 69. AUSTRALIA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 70. AUSTRALIA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 71. CHINA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 72. CHINA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 73. CHINA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
  • TABLE 74. CHINA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 75. CHINA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 76. INDIA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 77. INDIA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 78. INDIA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
  • TABLE 79. INDIA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 80. INDIA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 81. INDONESIA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 82. INDONESIA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 83. INDONESIA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
  • TABLE 84. INDONESIA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 85. INDONESIA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 86. JAPAN CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 87. JAPAN CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 88. JAPAN CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
  • TABLE 89. JAPAN CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 90. JAPAN CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 91. MALAYSIA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 92. MALAYSIA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 93. MALAYSIA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
  • TABLE 94. MALAYSIA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 95. MALAYSIA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 96. PHILIPPINES CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 97. PHILIPPINES CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 98. PHILIPPINES CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
  • TABLE 99. PHILIPPINES CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 100. PHILIPPINES CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 101. SINGAPORE CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 102. SINGAPORE CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 103. SINGAPORE CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
  • TABLE 104. SINGAPORE CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 105. SINGAPORE CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 106. SOUTH KOREA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 107. SOUTH KOREA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 108. SOUTH KOREA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
  • TABLE 109. SOUTH KOREA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 110. SOUTH KOREA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 111. TAIWAN CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 112. TAIWAN CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 113. TAIWAN CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
  • TABLE 114. TAIWAN CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 115. TAIWAN CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 116. THAILAND CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 117. THAILAND CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 118. THAILAND CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
  • TABLE 119. THAILAND CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 120. THAILAND CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 121. VIETNAM CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 122. VIETNAM CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 123. VIETNAM CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
  • TABLE 124. VIETNAM CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 125. VIETNAM CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 126. EUROPE, MIDDLE EAST & AFRICA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 127. EUROPE, MIDDLE EAST & AFRICA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 128. EUROPE, MIDDLE EAST & AFRICA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
  • TABLE 129. EUROPE, MIDDLE EAST & AFRICA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 130. EUROPE, MIDDLE EAST & AFRICA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 131. EUROPE, MIDDLE EAST & AFRICA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 132. DENMARK CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 133. DENMARK CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 134. DENMARK CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
  • TABLE 135. DENMARK CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 136. DENMARK CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 137. EGYPT CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 138. EGYPT CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 139. EGYPT CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
  • TABLE 140. EGYPT CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 141. EGYPT CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 142. FINLAND CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 143. FINLAND CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 144. FINLAND CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
  • TABLE 145. FINLAND CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 146. FINLAND CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 147. FRANCE CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 148. FRANCE CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 149. FRANCE CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
  • TABLE 150. FRANCE CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 151. FRANCE CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 152. GERMANY CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 153. GERMANY CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 154. GERMANY CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
  • TABLE 155. GERMANY CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 156. GERMANY CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 157. ISRAEL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 158. ISRAEL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 159. ISRAEL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
  • TABLE 160. ISRAEL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 161. ISRAEL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 162. ITALY CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 163. ITALY CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 164. ITALY CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
  • TABLE 165. ITALY CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 166. ITALY CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 167. NETHERLANDS CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 168. NETHERLANDS CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 169. NETHERLANDS CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
  • TABLE 170. NETHERLANDS CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 171. NETHERLANDS CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 172. NIGERIA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 173. NIGERIA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 174. NIGERIA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
  • TABLE 175. NIGERIA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 176. NIGERIA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 177. NORWAY CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 178. NORWAY CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 179. NORWAY CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
  • TABLE 180. NORWAY CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 181. NORWAY CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 182. POLAND CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 183. POLAND CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 184. POLAND CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
  • TABLE 185. POLAND CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 186. POLAND CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 187. QATAR CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 188. QATAR CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 189. QATAR CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
  • TABLE 190. QATAR CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 191. QATAR CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 192. RUSSIA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 193. RUSSIA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 194. RUSSIA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
  • TABLE 195. RUSSIA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 196. RUSSIA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 197. SAUDI ARABIA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 198. SAUDI ARABIA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 199. SAUDI ARABIA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
  • TABLE 200. SAUDI ARABIA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 201. SAUDI ARABIA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 202. SOUTH AFRICA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 203. SOUTH AFRICA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 204. SOUTH AFRICA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
  • TABLE 205. SOUTH AFRICA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 206. SOUTH AFRICA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 207. SPAIN CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 208. SPAIN CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 209. SPAIN CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
  • TABLE 210. SPAIN CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 211. SPAIN CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 212. SWEDEN CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 213. SWEDEN CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 214. SWEDEN CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
  • TABLE 215. SWEDEN CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 216. SWEDEN CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 217. SWITZERLAND CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 218. SWITZERLAND CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 219. SWITZERLAND CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
  • TABLE 220. SWITZERLAND CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 221. SWITZERLAND CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 222. TURKEY CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 223. TURKEY CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 224. TURKEY CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
  • TABLE 225. TURKEY CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 226. TURKEY CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 227. UNITED ARAB EMIRATES CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 228. UNITED ARAB EMIRATES CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 229. UNITED ARAB EMIRATES CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
  • TABLE 230. UNITED ARAB EMIRATES CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 231. UNITED ARAB EMIRATES CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 232. UNITED KINGDOM CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 233. UNITED KINGDOM CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 234. UNITED KINGDOM CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
  • TABLE 235. UNITED KINGDOM CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 236. UNITED KINGDOM CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 237. CONNECTED DRUG DELIVERY DEVICES MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 238. CONNECTED DRUG DELIVERY DEVICES MARKET, FPNV POSITIONING MATRIX, 2023